Nuclear medicine vendor ADAC Laboratories of Milpitas, CA, beganshipping its Molecular Coincidence Detection high-energy imagingupgrade this year, and reported that it had received 27 ordersfor MCD upgrades through the end of its fiscal year in
Nuclear medicine vendor ADAC Laboratories of Milpitas, CA, beganshipping its Molecular Coincidence Detection high-energy imagingupgrade this year, and reported that it had received 27 ordersfor MCD upgrades through the end of its fiscal year in September.ADAC plans to show improvements in reconstruction algorithms forMCD at its RSNA booth, according to Jeff Nelson, vice presidentof marketing.
Also look for ADAC to present final results of its multicenterclinical trial for Vantage, an attenuation-correction feature.The results indicate that Vantage can help reduce false positivesin nuclear cardiology studies, Nelson said. ADAC has developeda second-generation version of Vantage that incorporates scattercorrection and gated SPECT.
Vertex Plus is the third generation of ADAC's variable-angledual-head gamma camera, and features improvements to the system'sergonomics and patient handling, according to Nelson.
The most interesting news at ADAC's booth, however, isn't relatedto a new product, but rather an acquisition with intriguing ramifications:sources indicate the vendor will annouce the purchase of managedservice organization Medical Transition Strategies of Atlanta,the parent of Georgia Radiology Network.
ADAC is expected to form a new business unit to encompass itswork in developing physician networks that can contract with payorslike managed-care organizations. ADAC could use Georgia RadiologyNetwork as a model in setting up radiology networks in other states.The company declined to comment officially on the acquisitionprior to the RSNA show.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.
Systematic Review: PET/MRI May be More Advantageous than PET/CT in Cancer Imaging
July 18th 2024While PET/MRI and PET/CT had comparable sensitivity for patient-level regional nodal metastases and lesion-level recurrence, the authors of a systematic review noted that PET/MRI had significantly higher accuracy in breast cancer and colorectal cancer staging.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Enhanced Mobile CT System with High-Resolution Photon-Counting Technology
July 15th 2024Photon-counting CT-optimized features with the OmniTom Elite system include 30 cm field of view scanning, continuous spiral scanning, and an ultra-high-resolution capability of 0.141 mm resolution.